HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Neuroinflammation and Substance Use Disorders

Neuroinflammation and Substance Use Disorders

Neuroinflammation refers to inflammation in the brain, which can be triggered by chronic substance use. This inflammation plays a significant role in the development and progression of substance use disorders by altering neural signaling, neurotransmitter systems, and brain structure. Persistent neuroinflammation can lead to cognitive deficits, emotional dysregulation, and a heightened susceptibility to addiction. Recent research suggests that targeting neuroinflammation may be a promising avenue for addiction treatment, as reducing inflammation could potentially reverse some of the cognitive and emotional impairments caused by substance use. Anti-inflammatory treatments, alongside traditional therapies, may provide new hope for individuals struggling with addiction.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John Giordano

John Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies, United Kingdom
Tags

Submit your abstract Today

Whatsapp